Premature Births Completed Phase 2 / 3 Trials for Palivizumab (DB00110)

Also known as: PreTerm Birth / Premature Birth / Birth premature / Premature birth, NOS / Early onset of delivery / Premature delivery / Premature baby / Baby premature / Immature baby / 28 completed weeks or more but less than 37 completed weeks (196 completed days but less than 259 completed days) of gestation. / Prematurity / Infant premature

IndicationStatusPhase
DBCOND0043809 (Premature Births)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01006629Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian ChildrenPrevention